Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery

Abstract

In patients with severe aortic stenosis who were not suitable candidates for surgery, TAVI, as compared with standard therapy, significantly reduced the rates of death from any cause, the composite end point of death from any cause or repeat hospitalization, and cardiac symptoms, despite the higher incidence of major strokes and major vascular events. (Funded by Edwards Lifesciences; ClinicalTrials.gov number, NCT00530894.).

Keywords

Affiliated Institutions

• Cleveland Clinic US
• Columbia University Irving Medical Center US
• New York Hospital Queens US
• Hospital of the University of Pennsylvania US
• NewYork–Presbyterian Hospital US
• London School of Hygiene & Tropical Medicine GB
• Duke Medical Center US
• Stanford University US
• St. Paul's Hospital CA
• Medical City Dallas Hospital US
• Emory University US
• MedStar Washington Hospital Center US
• University of British Columbia CA
• Edwards Lifesciences (United States) US
• Cedars-Sinai Medical Center US

Related Publications